Company news
Firefly Neuroscience, Inc. news in 2026
Firefly Neuroscience, Inc.'s news releases, calls and decks from 2026, newest first.
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform
October 27, 2026
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
September 25, 2026
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
August 5, 2026
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
July 27, 2026
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
June 1, 2026
With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository
April 13, 2026
Firefly Confirms Public-Private Partnership with the Department of War
March 26, 2026
Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD
March 12, 2026
Firefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration
March 4, 2026